GPLD1 and neoplasm: In another study, PLD was conjugated with a short peptide, namely P700, which has the ability to bind multiple tumor-overexpressed tyrosine kinase receptors, including vascular endothelial growth factor receptors (VEGFR 2, 3), platelet-derived growth factor (PDGFRa) and fibroblast growth factor receptor1 (FGFR1).